Analystreport

BIOLASE, Inc. (NASDAQ: BIOL) had its price target lowered by analysts at Lake Street Capital to $1.50.

BIOLASE INC  (BIOL) 
Last biolase inc earnings: 3/26 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: biolase.com/investors